Recent data shows a continued and significant decline in the use of menopause hormone therapy among women in the United States. Despite strong clinical evidence supporting its effectiveness for managing menopausal symptoms in many patients, usage rates remain historically low. A large-scale study published in Mayo Clinic Proceedings highlights that hormone therapy adoption has dropped sharply over the past two decades, raising questions about patient awareness, medical guidance, and long-term perceptions of risk.
This article explores the latest findings, why hormone therapy use is decreasing, and what it could mean for women experiencing menopause today.
According to research summarized by HealthDay News and reviewed by clinicians associated with the Mayo Clinic, hormone therapy use among women aged 40 and older declined from 4.4 percent in 2007 to just 1.7 percent in 2023. This represents a substantial reduction over time, despite increasing awareness of menopause and expanded treatment options.
Even among women aged 50 to 59, who are often considered the group most likely to benefit from hormone therapy, usage remains low at approximately 3.5 percent in 2023.
The study analyzed nationwide healthcare and pharmacy claims data from a large United States database, tracking prescribing trends over a 16 year period. The results show a consistent downward trajectory rather than a temporary fluctuation.
Researchers suggest that the decline is not driven by lack of effectiveness, but rather by long-standing concerns about safety that have persisted for more than two decades.
A major turning point occurred in 2002 following the Women’s Health Initiative clinical trial. Early findings from that study raised concerns that hormone therapy could increase risks such as cardiovascular disease. These findings had a major impact on both public perception and clinical practice.
Although later reanalysis of the same data showed that risks vary significantly depending on age and individual health status, the initial message had already influenced medical guidance and patient attitudes.
Dr. Stephanie Faubion, a menopause specialist at the Mayo Clinic, noted that for many women in their 50s, hormone therapy can be both safe and effective. However, the early warning messages created lasting caution among both patients and healthcare providers.
One of the key issues highlighted by researchers is ongoing misunderstanding about the risks and benefits of hormone therapy.
Many women continue to associate hormone therapy with high cardiovascular risk, even though more recent evidence suggests that risk is relatively low for healthy women in early menopause. This gap between updated clinical evidence and public perception has contributed to continued underuse.
Another challenge is variation in physician training. Some healthcare providers may not receive extensive education on menopause management or updated hormone therapy guidelines. As a result, they may be less likely to prescribe these treatments or discuss them in detail with patients.
Experts emphasize that improving education for both clinicians and patients is essential to closing this gap.
The study also found disparities in hormone therapy use among different racial and ethnic groups. Usage was higher among white women compared to Black, Hispanic, and Asian American women.
While the study does not fully explain the reasons for this difference, it suggests that access to care, cultural perceptions, healthcare communication, and systemic inequities may all play a role. These disparities highlight the need for more inclusive menopause care and better outreach across diverse communities.
Menopause can bring a wide range of symptoms, including hot flashes, night sweats, sleep disturbances, mood changes, and vaginal dryness. For many women, these symptoms can significantly affect quality of life.
Hormone therapy, when appropriately prescribed, can be highly effective in reducing these symptoms. In some cases, it can also help prevent bone loss associated with postmenopausal osteoporosis.
However, treatment decisions are highly individual. Factors such as age, medical history, cardiovascular risk, and time since menopause onset all influence whether hormone therapy is appropriate.
Modern research has refined earlier conclusions about hormone therapy. Scientists now understand that risks are not uniform across all age groups.
For example, women who begin hormone therapy closer to the onset of menopause, particularly in their 50s, tend to have different risk profiles compared to older women starting therapy later in life. This more nuanced understanding supports personalized treatment decisions rather than a one size fits all approach.
Despite this, outdated perceptions continue to influence decision making in both clinical and non clinical settings.
Experts from the Mayo Clinic and other institutions emphasize the importance of improving education around menopause care. This includes:
Improved awareness could help ensure that women who may benefit from hormone therapy are able to make informed decisions based on current evidence rather than outdated concerns.
The decline in menopause hormone therapy use in the United States reflects a complex combination of historical concerns, persistent misconceptions, and gaps in medical education. While usage rates have dropped significantly since the early 2000s, current evidence suggests that hormone therapy remains a safe and effective option for many women when appropriately prescribed.
As research continues to refine understanding of menopause treatment, the focus is shifting toward personalized care and improved education. Bridging the gap between scientific evidence and clinical practice will be key to ensuring that women receive the most appropriate care for their individual needs.
This article is for informational and educational purposes only. It is not intended to provide medical advice, diagnosis, or treatment. Medical decisions should always be made in consultation with a qualified healthcare professional who can evaluate individual circumstances. Statistical trends described in medical research do not apply to every individual, and treatment suitability varies based on personal health history and risk factors.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.